Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
Status: Enrolling
Updated:  5/6/2013
Sansum Diabetes Research Institute
mi
from
Santa Barbara, CA
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
Status: Enrolling
Updated: 5/6/2013
Sansum Diabetes Research Institute
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects
A Phase 1 Placebo-Controlled Study To Assess Safety, Tolerability, Pharmacokinetics And Effect On Midazolam Pharmacokinetics Of Multiple Oral Doses Of PF-05175157 Administered In A Tablet Formulation In Otherwise Healthy Overweight And Obese Subjects
Status: Enrolling
Updated:  5/6/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Multiple Dose Safety Tolerability, Pharmacokinetics And Midazolam Interaction In Healthy Overweight And Obese Subjects
A Phase 1 Placebo-Controlled Study To Assess Safety, Tolerability, Pharmacokinetics And Effect On Midazolam Pharmacokinetics Of Multiple Oral Doses Of PF-05175157 Administered In A Tablet Formulation In Otherwise Healthy Overweight And Obese Subjects
Status: Enrolling
Updated: 5/6/2013
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
Institute for Advanced Wound Care at Baptist Medical
mi
from
Montgomery, AL
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
Institute for Advanced Wound Care at Baptist Medical
mi
from
Montgomery, AL
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
Clinical Trials of Arizona, Inc
mi
from
Glendale, AZ
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
Clinical Trials of Arizona, Inc
mi
from
Glendale, AZ
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
ILD Laser and Research Center
mi
from
Encinitas, CA
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
ILD Laser and Research Center
mi
from
Encinitas, CA
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
Nature Coast Clinical Research
mi
from
Inverness, FL
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
Nature Coast Clinical Research
mi
from
Inverness, FL
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
River City Clinical Research
mi
from
Jacksonville, FL
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
River City Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
Aiyan Diabetes Center
mi
from
Augusta, GA
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
Aiyan Diabetes Center
mi
from
Augusta, GA
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
Ocean County Foot & Ankle Surgical Associates
mi
from
Toms River, NJ
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
Ocean County Foot & Ankle Surgical Associates
mi
from
Toms River, NJ
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
UNC Chapel Hill
mi
from
CHapel Hill, NC
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
UNC Chapel Hill
mi
from
CHapel Hill, NC
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
Cleveland Clinic
mi
from
Cleveland, OH
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
Ohio Health Research Institute
mi
from
Columbus, OH
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
Ohio Health Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
Blair Orthopedics Associates, Inc
mi
from
Altoona, PA
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
Blair Orthopedics Associates, Inc
mi
from
Altoona, PA
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
Omega Medical Research
mi
from
Warwick, RI
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
Omega Medical Research
mi
from
Warwick, RI
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
UT Southwestern Medical Center at Dallas
mi
from
Dallas, TX
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
UT Southwestern Medical Center at Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated:  5/8/2013
Clincal Trials of Texas, Inc.
mi
from
San Antonio, TX
Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers
A Multicenter, Adaptive Design, Randomized, Single-Blind Study With an Open-Label Extension Option to Further Evaluate the Safety and Efficacy of Grafix® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling
Updated: 5/8/2013
Clincal Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluation of a Nutritional Product for People With Type 2 Diabetes
Evaluation of a Nutritional Product for People With Type 2 Diabetes (T2DM)
Status: Enrolling
Updated:  5/8/2013
Radiant Research Inc.
mi
from
Chicago, IL
Evaluation of a Nutritional Product for People With Type 2 Diabetes
Evaluation of a Nutritional Product for People With Type 2 Diabetes (T2DM)
Status: Enrolling
Updated: 5/8/2013
Radiant Research Inc.
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluation of a Nutritional Product for People With Type 2 Diabetes
Evaluation of a Nutritional Product for People With Type 2 Diabetes (T2DM)
Status: Enrolling
Updated:  5/8/2013
Radiant Research, Inc.
mi
from
Cincinnati, OH
Evaluation of a Nutritional Product for People With Type 2 Diabetes
Evaluation of a Nutritional Product for People With Type 2 Diabetes (T2DM)
Status: Enrolling
Updated: 5/8/2013
Radiant Research, Inc.
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease
Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease
Status: Enrolling
Updated:  5/13/2013
University of Utah
mi
from
Salt Lake City, UT
Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease
Effects of Febuxostat on Adipokines and Kidney Disease in Diabetic Chronic Kidney Disease
Status: Enrolling
Updated: 5/13/2013
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Comprehensive Postpartum Screening Strategies for Women With Gestational Diabetes Mellitus (GDM)
Comprehensive Postpartum Screening Strategies for Women With Prior Gestational Diabetes (COPSS - GDM): Now is the Time for a Paradigm Shift in Clinical Practice
Status: Enrolling
Updated:  5/14/2013
Woman's Hospital Research Institute
mi
from
Baton Rouge, LA
Comprehensive Postpartum Screening Strategies for Women With Gestational Diabetes Mellitus (GDM)
Comprehensive Postpartum Screening Strategies for Women With Prior Gestational Diabetes (COPSS - GDM): Now is the Time for a Paradigm Shift in Clinical Practice
Status: Enrolling
Updated: 5/14/2013
Woman's Hospital Research Institute
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Bone Mineral Density in Childhood and Adolescence
Type 1 DM Bone Mineral Density in Childhood and Adolescence
Status: Enrolling
Updated:  5/15/2013
Creighton University
mi
from
Omaha, NE
Type 1 Diabetes Mellitus Bone Mineral Density in Childhood and Adolescence
Type 1 DM Bone Mineral Density in Childhood and Adolescence
Status: Enrolling
Updated: 5/15/2013
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
A Pilot Study to Determine the Effects of a Single Dose of Exenatide (Byetta ®) on the Acute Metabolic Responses to a Mixed Meal or Intravenous Glucose Tolerance Test in Patients With Type 1 Diabetes
Status: Enrolling
Updated:  5/15/2013
Yale School of Medicine
mi
from
New Haven, CT
Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
A Pilot Study to Determine the Effects of a Single Dose of Exenatide (Byetta ®) on the Acute Metabolic Responses to a Mixed Meal or Intravenous Glucose Tolerance Test in Patients With Type 1 Diabetes
Status: Enrolling
Updated: 5/15/2013
Yale School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Statins in Children With Type 1 Diabetes: Effects on Metabolism, Inflammation and Endothelial Function
Status: Enrolling
Updated:  5/19/2013
Alfred I duPont Hospital
mi
from
Wilmington, DE
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Statins in Children With Type 1 Diabetes: Effects on Metabolism, Inflammation and Endothelial Function
Status: Enrolling
Updated: 5/19/2013
Alfred I duPont Hospital
mi
from
Wilmington, DE
Click here to add this to my saved trials
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Statins in Children With Type 1 Diabetes: Effects on Metabolism, Inflammation and Endothelial Function
Status: Enrolling
Updated:  5/19/2013
Nemours Children's Clinic
mi
from
Jacksonville, FL
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Statins in Children With Type 1 Diabetes: Effects on Metabolism, Inflammation and Endothelial Function
Status: Enrolling
Updated: 5/19/2013
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Statins in Children With Type 1 Diabetes: Effects on Metabolism, Inflammation and Endothelial Function
Status: Enrolling
Updated:  5/19/2013
Nemours Children's Clinic-Jefferson
mi
from
Philadelphia, PA
Statins in Children With Type 1 Diabetes and Hypercholesterolemia
Statins in Children With Type 1 Diabetes: Effects on Metabolism, Inflammation and Endothelial Function
Status: Enrolling
Updated: 5/19/2013
Nemours Children's Clinic-Jefferson
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effects of Aerobic Exercise in Patients With Pre-diabetes
The Effect of Controlled Aerobic Exercise on Endothelial Dysfunction and Vascular Reactivity in Patients With Pre-diabetes: A Crossover Pilot Study
Status: Enrolling
Updated:  5/20/2013
Baystate Medical Center
mi
from
Springfield, MA
Effects of Aerobic Exercise in Patients With Pre-diabetes
The Effect of Controlled Aerobic Exercise on Endothelial Dysfunction and Vascular Reactivity in Patients With Pre-diabetes: A Crossover Pilot Study
Status: Enrolling
Updated: 5/20/2013
Baystate Medical Center
mi
from
Springfield, MA
Click here to add this to my saved trials
Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 Following Single and Multiple Ascending Doses in Healthy Subjects and Patients With Type 2 Diabetes
Status: Enrolling
Updated:  5/21/2013
Novartis Investigative site
mi
from
Los Angeles, CA
Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 Following Single and Multiple Ascending Doses in Healthy Subjects and Patients With Type 2 Diabetes
Status: Enrolling
Updated: 5/21/2013
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 Following Single and Multiple Ascending Doses in Healthy Subjects and Patients With Type 2 Diabetes
Status: Enrolling
Updated:  5/21/2013
Novartis Investigative Site
mi
from
Miami, FL
Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 Following Single and Multiple Ascending Doses in Healthy Subjects and Patients With Type 2 Diabetes
Status: Enrolling
Updated: 5/21/2013
Novartis Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 Following Single and Multiple Ascending Doses in Healthy Subjects and Patients With Type 2 Diabetes
Status: Enrolling
Updated:  5/21/2013
Novartis Investigative Site
mi
from
Knoxville, TN
Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 Following Single and Multiple Ascending Doses in Healthy Subjects and Patients With Type 2 Diabetes
Status: Enrolling
Updated: 5/21/2013
Novartis Investigative Site
mi
from
Knoxville, TN
Click here to add this to my saved trials
Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 Following Single and Multiple Ascending Doses in Healthy Subjects and Patients With Type 2 Diabetes
Status: Enrolling
Updated:  5/21/2013
Novartis Investigative site
mi
from
Dallas, TX
Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763 Following Single and Multiple Ascending Doses in Healthy Subjects and Patients With Type 2 Diabetes
Status: Enrolling
Updated: 5/21/2013
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS)
Artificial Pancreas Device Feasibility Study for Type 1 Diabetes Patients Using Model-predictive Control and Health Monitoring System Algorithms With an Approved Subcutaneous Insulin Delivery Pump and Subcutaneous Continuous Glucose Monitor
Status: Enrolling
Updated:  5/22/2013
Sansum Diabetes Research Institute
mi
from
Santa Barbara, CA
Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS)
Artificial Pancreas Device Feasibility Study for Type 1 Diabetes Patients Using Model-predictive Control and Health Monitoring System Algorithms With an Approved Subcutaneous Insulin Delivery Pump and Subcutaneous Continuous Glucose Monitor
Status: Enrolling
Updated: 5/22/2013
Sansum Diabetes Research Institute
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Gastrointestinal Microbiome
A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Fecal Bacteroidetes: Firmicutes Ratio in Pre-Diabetic Subjects.
Status: Enrolling
Updated:  5/30/2013
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Gastrointestinal Microbiome
A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Fecal Bacteroidetes: Firmicutes Ratio in Pre-Diabetic Subjects.
Status: Enrolling
Updated: 5/30/2013
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Artificial Pancreas Control System in an Outpatient Setting
Sensor-controlled Insulin- and Glucagon Delivery in Subjects With Type 1 Diabetes: Testing of an Automated System in an Outpatient (Hotel) Setting.
Status: Enrolling
Updated:  6/4/2013
Legacy Research Institute
mi
from
Portland, OR
Artificial Pancreas Control System in an Outpatient Setting
Sensor-controlled Insulin- and Glucagon Delivery in Subjects With Type 1 Diabetes: Testing of an Automated System in an Outpatient (Hotel) Setting.
Status: Enrolling
Updated: 6/4/2013
Legacy Research Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients
Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients
Status: Enrolling
Updated:  6/6/2013
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients
Insulin Pre-treatment for Steroid-associated Hyperglycemia in Pregnant Diabetic Patients
Status: Enrolling
Updated: 6/6/2013
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.
Evaluation of Quercetin in Type 2 Diabetes: Impact on Glucose Tolerance and Postprandial Endothelial Function.
Status: Enrolling
Updated:  6/13/2013
Bastyr Center for Natural Health
mi
from
Seattle, WA
Effects of Quercetin on Blood Sugar and Blood Vessel Function in Type 2 Diabetes.
Evaluation of Quercetin in Type 2 Diabetes: Impact on Glucose Tolerance and Postprandial Endothelial Function.
Status: Enrolling
Updated: 6/13/2013
Bastyr Center for Natural Health
mi
from
Seattle, WA
Click here to add this to my saved trials
Effects of Metreleptin in Type 1 Diabetes Mellitus
Open Label Single Center Pilot Study to Study Teh Effects of Metreleptin Administration in Patients With Type 1 Diabetes Mellitus ( T1DM ).
Status: Enrolling
Updated:  6/19/2013
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Effects of Metreleptin in Type 1 Diabetes Mellitus
Open Label Single Center Pilot Study to Study Teh Effects of Metreleptin Administration in Patients With Type 1 Diabetes Mellitus ( T1DM ).
Status: Enrolling
Updated: 6/19/2013
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Effects of Standing on Glycemia in Prediabetic Adults
Acute Effects of Standing on Glycemia in Prediabetic Adults: A Pilot Study
Status: Enrolling
Updated:  6/21/2013
Department of Human Services
mi
from
St. Paul, MN
Effects of Standing on Glycemia in Prediabetic Adults
Acute Effects of Standing on Glycemia in Prediabetic Adults: A Pilot Study
Status: Enrolling
Updated: 6/21/2013
Department of Human Services
mi
from
St. Paul, MN
Click here to add this to my saved trials
Gluconeogenesis Rates and Its Precursors in Pediatric Sepsis
Gluconeogenesis Rates and Its Source in Critically Ill Adolescents
Status: Enrolling
Updated:  6/27/2013
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Gluconeogenesis Rates and Its Precursors in Pediatric Sepsis
Gluconeogenesis Rates and Its Source in Critically Ill Adolescents
Status: Enrolling
Updated: 6/27/2013
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated:  6/28/2013
St. Luke's Roosevelt Hospital
mi
from
New York, NY
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated: 6/28/2013
St. Luke's Roosevelt Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated:  6/28/2013
Univ of Pennsylvania
mi
from
Philadelphia, PA
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated: 6/28/2013
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated:  6/28/2013
University of Pittsburgh
mi
from
Pittsburgh, PA
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated: 6/28/2013
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated:  6/28/2013
Brown University
mi
from
Providence, RI
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Sleep Apnea in Look AHEAD (Action for Health in Diabetes)
Status: Enrolling
Updated: 6/28/2013
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test on DFU
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test A Prospective, Multi Centre, Randomised, Clinical Study on Diabetic Foot Ulcers
Status: Enrolling
Updated:  7/4/2013
Penn North Centers for Advance Wound Care
mi
from
Eire, PA
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test on DFU
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test A Prospective, Multi Centre, Randomised, Clinical Study on Diabetic Foot Ulcers
Status: Enrolling
Updated: 7/4/2013
Penn North Centers for Advance Wound Care
mi
from
Eire, PA
Click here to add this to my saved trials
Diabetes in the Elderly: Prospective Study
Diabetes Care in Nursing Home Residents: A Randomized Controlled Study
Status: Enrolling
Updated:  7/9/2013
Guillermo Umpierrez
mi
from
Atlanta, GA
Diabetes in the Elderly: Prospective Study
Diabetes Care in Nursing Home Residents: A Randomized Controlled Study
Status: Enrolling
Updated: 7/9/2013
Guillermo Umpierrez
mi
from
Atlanta, GA
Click here to add this to my saved trials
PGC-1 and Mitochondrial Dysfunction in Diabetes
PGC-1 and Mitochondrial Dysfunction in Diabetes
Status: Enrolling
Updated:  7/11/2013
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
PGC-1 and Mitochondrial Dysfunction in Diabetes
PGC-1 and Mitochondrial Dysfunction in Diabetes
Status: Enrolling
Updated: 7/11/2013
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Lifestyle Improvement Through Food and Exercise (LIFE)Study
Lifestyle Improvement Through Food and Exercise (LIFE) Study
Status: Enrolling
Updated:  7/15/2013
Cook County Health Clinics
mi
from
Chicago, IL
Lifestyle Improvement Through Food and Exercise (LIFE)Study
Lifestyle Improvement Through Food and Exercise (LIFE) Study
Status: Enrolling
Updated: 7/15/2013
Cook County Health Clinics
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety, Pharmacokinetics and Pharmacodynamics of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Multiple Oral Bedtime Doses of ORMD-0801(Insulin Capsules) in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Exercise or Diet, Exercise and Metformin
Status: Enrolling
Updated:  7/17/2013
Orange County Research Center
mi
from
Tustin, CA
Safety, Pharmacokinetics and Pharmacodynamics of Multiple Oral Bedtime Doses of ORMD-0801 in Adult Patients With Type 2 Diabetes
Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of Multiple Oral Bedtime Doses of ORMD-0801(Insulin Capsules) in Adult Patients With Type 2 Diabetes Mellitus Who Are Inadequately Controlled With Diet and Exercise or Diet, Exercise and Metformin
Status: Enrolling
Updated: 7/17/2013
Orange County Research Center
mi
from
Tustin, CA
Click here to add this to my saved trials
Performance Evaluation of a Non-Invasive Glucose Monitor as Compared to CGM Data Acquired by the iPro2
Performance Evaluation of a Non-Invasive Glucose Monitor (Spectral Data Acquisition) as Compared to CGM Data Acquired by the iPro2
Status: Enrolling
Updated:  7/22/2013
Sansum Diabetes Research Institute
mi
from
Santa Barbara, CA
Performance Evaluation of a Non-Invasive Glucose Monitor as Compared to CGM Data Acquired by the iPro2
Performance Evaluation of a Non-Invasive Glucose Monitor (Spectral Data Acquisition) as Compared to CGM Data Acquired by the iPro2
Status: Enrolling
Updated: 7/22/2013
Sansum Diabetes Research Institute
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM
Evaluation of the Pharmacokinetics of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus Following Oral Administration of Saxagliptin and Metformin XR Fixed Dose Combination Tablet and Co-Administration of Saxagliptin and Glucophage® (Metformin) IR Tablets
Status: Enrolling
Updated:  7/26/2013
Osborne Research Center
mi
from
Little Rock, AR
Study of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin Concentrations/Levels in Pediatric Subjects With T2DM
Evaluation of the Pharmacokinetics of Saxagliptin, 5-Hydroxy Saxagliptin, and Metformin in Children and Adolescents Aged 10 to 17 Years With Type 2 Diabetes Mellitus Following Oral Administration of Saxagliptin and Metformin XR Fixed Dose Combination Tablet and Co-Administration of Saxagliptin and Glucophage® (Metformin) IR Tablets
Status: Enrolling
Updated: 7/26/2013
Osborne Research Center
mi
from
Little Rock, AR
Click here to add this to my saved trials